World Cancer Day
A multidisciplinary and collaborative approach
From cell biology and genetics, to medical imaging and clinical trials, UCL brings together the greatest expertise across the disciplines of life and medical sciences, social sciences and engineering to understand cancer and develop safer, more effective treatments.
Training the next generation of researchers and clinicians
UCL's research-based education engages students with the very latest knowledge and thinking and empowers them, step by step, to apply the skills and dispositions needed to study, treat and manage cancer.
Early stage researcher, Morgan Palton, on immunotherapy and glioblastoma
Undergraduate study | Cancer Biomedicine BSc
New approaches to understanding and treating brain tumours
UCL Innovation and Enterprise
Every thriving business, life-saving medicine and revolutionary technology begins as an idea. UCL students, staff and partners come together to turn knowledge and ideas into the solutions that benefit us all.
Founded in 2018, by UCL Computer Science PhD students Leo Wossnig and Ed Grant - alongside entrepreneurs Miriam Cha and Ian Horobin - machine learning company, Rahko, has been bought by US-based biotechnology firm, Odyssey Therapeutics, in a move that will bring together artificial intelligence and drug-discovery software to improve medical development for patients with cancer and inflammatory disease.
The power of philanthropy to advance cancer therapies
Philanthropic giving plays a vital part in supporting and accelerating cancer research and education, so that discoveries made in the lab can be translated to the clinic sooner.
The Edward Showler Foundation and UCL have forged a philanthropic partnership that will support pioneering research into clear cell sarcoma (CCS) – a rare type of soft tissue cancer with few available treatments.
Dr Claire Roddie and Professor Tariq Enver have been awarded an ASPIRE award for their work on T-cell reprogramming for the treatment of cancers. They plan to ‘super charge’ Tumour Infiltrating Lymphocyte (TIL) therapy for cancer. The award has been made by US-based philanthropic organisation, The Mark Foundation for Cancer Research.
UCL Cancer Institute's life-saving work has been bolstered by a £1.875 million donation from Sir Peter Wood CBE that will fund vital research, equipment and educational opportunities.
"The real impact of philanthropy is that it gives the brightest minds the freedom to think – and do – differently; that is where breakthroughs happen.” Professor Tariq Enver, Director, UCL Cancer Institute.
If you are interested in learning more about supporting our cancer research please contact firstname.lastname@example.org
Made at UCL
Through our research, many minds at UCL work together to improve lives and communities and create real world impact. Find out more about the disruptive discoveries from UCL that are transforming healthcare.
#MadeatUCL Podcast: Maps
Prof Mark Emberton, surgeon, urologist and the Dean of Medical Sciences at UCL, explains how MRI and ultrasound are transforming diagnosis and treatment of prostate cancer.
#MadeatUCL | Targeted Radiotherapy
A pioneering breast cancer therapy developed by UCL clinicians requires just one shot of radiotherapy rather than conventional weeks-long treatment.
Catch up with the latest Brain Cancer scientific seminar featuring:
Laura K. Donovan - (UCL GOS ICH) The basic science of CAR T-cells and challenges facing the treatment of aggressive paediatric brain tumours
Mathew Voisin - (UoT) Determining the underlying mechanisms of glioma progression and recurrence
12 October 2022 12:00 - 13:00 BST
Public lecture series
Catch up with UCL's online lectures - virtual events designed to inspire and inform.
The Big "C" | UCL Medical Sciences Public Lecture
Can we use the immune system to fight cancer
Radiation physics in medicine | Spring into STEM
Cancer Research UK has confirmed The CRUK City of London Centre, led by Professor Tariq Enver (UCL Cancer Institute), will continue to research and develop pioneering new biotheraputics, as part of a new £100 million investment.
People who survive cancer early in their life have higher risks of ill health as they grow older, and these risks vary according to the cancer type and how the cancer was treated, a new study by UCL researchers has found.